Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Číst více
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Číst více
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Číst více
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Číst více
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Číst více

Which Type Is It?

Číst více
무작위 배정 임상 3b상 HARMONIE 연구에서 180일 동안의 Nirsevimab 유효성 분석

무작위 배정 임상 3b상 HARMONIE 연구에서 180일 동안의 Nirsevimab 유효성 분석

Efficacy of Nirsevimab Over 6 Months: A 180-Day Endpoint Analysis from the HARMONIE Study, a Randomized Phase IIIb trial
Alasdair P.S. Munro, PhD1, 2., Simon B. Drysdale, PhD., FRCPCH3, 4., Katrina Cathie, MD., FRCPCH1, 2., Florence Flamein, MD., PhD5, 6., Markus Knuf, PhD7, 8., Andrea M. Collins, MD., PhD9,10., Helen C. Hill, PhD9., Friedrich Kaiser, MD11., Robert Cohen, MD12., Didier Pinquier, MD13., Natalya C. Vassilouthis, MD14., Mariana Carreno, MD15., Catherine Moreau, MSc16., Pierre Bourron, PharmD17., Lydie Marcelon, PhD18., Karine Mari, PhD19., Michelle Roberts, MD20., Pierre Tissières, MD., DSc21,22., Simon Royal, MPH., MRCGP23., and Saul N. Faust, PhD., FRCPCH1, 2., for the HARMONIE Study Group. doi:10.2139/ssrn.4995419..

Číst více
Diyabetli bireylerde RAS blokerlerinin Kardiyovasküler ve Renal etki Meta Analizi

Diyabetli bireylerde RAS blokerlerinin Kardiyovasküler ve Renal etki Meta Analizi

Číst více
Insight

Insight

Číst více
Infekce RSV u dětí v prvním roce života, Prof. MUDr. Petr Pazdiora, CSc.; Ondřej Šanca

Infekce RSV u dětí v prvním roce života, Prof. MUDr. Petr Pazdiora, CSc.; Ondřej Šanca

Číst více
Anti-EGFR 항체 치료 후 질병이 진행된 전이성 대장암 환자의 2차 요법으로서 Aflibercept와 FOLFIRI : 다기관, 전향적, 2상 임상시험(HGCSG1801)

Anti-EGFR 항체 치료 후 질병이 진행된 전이성 대장암 환자의 2차 요법으로서 Aflibercept와 FOLFIRI : 다기관, 전향적, 2상 임상시험(HGCSG1801)

A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
Nakatsumi H, et al. Int J Cancer. 2024 Dec 15;155(12):2223-2231

Číst více
Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

Číst více